The Latest Breaking News from the Food and Drug Administration

After botching COVID test approvals, the Food and Drug Administration wants power over thousands of other tests.

Vaccines, gender-affirming care and birth control could be next if SCOTUS rules to restrict nationwide access

Biotech stock Rapt plummeted to a record low Tuesday after the Food and Drug Administration put two of its clinical studies on hold.

Health officials reported 10 cases of E. coli infection, adding that the number of people sick is likely "much higher." Those cases were from California, Colorado, Texas and Utah.

People who are immunocompromised continue to worry about COVID. A raft of products promise protection. Is there any evidence they can protect from infection or lessen severity of disease?

UK-based company Haleon recalls eight batches of cough syrup over risk to immunocompromised individuals

The Checks and Balances Letter delivers news and information from Ballotpedia’s Administrative State Project, including pivotal actions at the federal and state levels related to the separation of powers, due process, and the rule of law.

While as little as one injection of penicillin G benzathine can cure syphilis, the shortage prompted U.S. health officials to recommend giving some patients another antibiotic that requires of weeks of twice-daily pills.

An excerpt from a long report and recommendation released Wednesday by Magistrate Judge Ona Wang (S.D.N.Y.) in Cassava Sciences, Inc. v. Bredt; for more details, read the whole opinion: At various dates in 2021, the Neuroscientist Defendants filed a Citizen Petition and sent publicly available letters to the Food and…